LivaNova’s proprietary PolySync algorithm allows for proximal hypoglossal nerve stimulation (p-HGNS) stimulation fields to be ...

Overview: Artificial intelligence allows algorithms to learn patterns and make smart decisions without fixed ...

Presentation at SLEEP 2026 illustrates ability to convert non-responders into responders using personalized programming ...

New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...

Overview: Social media algorithms personalize content by analyzing watch time, engagement, and user behavior to determine ...

LivaNova LIVN recently announced new data from the PolySync substudy showing that its PolySync programming algorithm increased the cumulative apnea-hypopnea index (AHI) response rate from 65% to 84.5% ...

For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of ...

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

NEW YORK, NY—A systematic program designed to close the diagnosis and treatment gaps for patients with aortic stenosis (AS) ...

Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...

Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced it has received ...

AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AK-AVS™ aortic valve stenosis (AVS) screening software has been accepted into the U.S. Food and Drug ...